-
[1]
Kun-xue HONG, Xiao-zhi LU, Guang-ming QIN, Jian-ping CHEN, Yu-hua RUAN, Hui XING, Jia-hong ZHU, Yi-ming SHAO, 2007: Relationship of HLA-A, -Cw Polymorphisms with HIV/AIDS in Chinese Yi Ethnic Group of Sichuan Province*, Virologica Sinica, 22, 301-306.
-
[2]
Wen-yuan YIN, Zun-you WU, 2007: Challenges and Opportunities: the Expanded Government-led HIV/AIDS Programs in China, Virologica Sinica, 22, 493-500.
-
[3]
Yi ZENG, 2007: Strategy for AIDS Prevention and Treatment, Virologica Sinica, 22, 419-420.
-
[4]
Yan Yan, Yong Ren, Renfang Chen, Jing Hu, Yongjia Ji, Junyang Yang, Jiayin Shen, Lvyin Hu, Hao Pei, Jun Wang, Yuanwang Qiu, Hongzhou Lu, Lihua Huang, 2018: Evaluation of Epstein-Barr Virus Salivary Shedding in HIV/AIDS Patients and HAART Use: A Retrospective Cohort Study, Virologica Sinica, 33, 227-233. doi: 10.1007/s12250-018-0028-z
-
[5]
Chang LI, Qin-xue HU, 2009: Driving Forces of AIDS Pathogenesis: Massive CD4+ T Lymphocyte Depletion and Abnormal Immune Activation, Virologica Sinica, 24, 501-508. doi: 10.1007/s12250-009-3063-y
-
[6]
Zhihao Zhang, Wei Hou, Shuliang Chen, 2022: Updates on CRISPR-based gene editing in HIV-1/AIDS therapy, Virologica Sinica, 37, 1-10. doi: 10.1016/j.virs.2022.01.017
-
[7]
陈火胜, 1994: Universal Primer PCR Technology:A General Introduction of Applications, Virologica Sinica, 9, 279-.
-
[8]
Wenyi Guan, Wendong Lan, Jing Zhang, Shan Zhao, Junxian Ou, Xiaowei Wu, Yuqian Yan, Jianguo Wu, Qiwei Zhang, 2020: COVID-19: Antiviral Agents, Antibody Development and Traditional Chinese Medicine, Virologica Sinica, 35, 685-698. doi: 10.1007/s12250-020-00297-0
-
[9]
Xiao-Jie Li, Rie Uenishi, Saiki Hase, Huanan Liao, Tee Kok Keng, Shigeru Kusagawa, Yutaka Takebe, 2007: HIV/AIDS in Asia: The Shape of Epidemics and Their Molecular Epidemiology, Virologica Sinica, 22, 424-433.
-
[10]
张 颖*, 白雪帆, 黄长形, 白宪光, 2004: HIV-1 Coreceptors and Coreceptor-related AIDS Therapy, Virologica Sinica, 19, 182-186.
-
[11]
Yan JIANG, 2007: Development and Challenge of HIV/AIDS Testing Laboratory Network and Quality Assurance System in China, Virologica Sinica, 22, 434-442.
-
[12]
Zhihao Zhang, Wei Hou, Shuliang Chen, 0: Updates on CRISPR-based gene editing in HIV-1/AIDS therapy, Virologica Sinica.
-
[13]
Patrick Buerger, Caroline Hauxwell, David Murray, 2007: Nucleopolyhedrovirus Introduction in Australia, Virologica Sinica, 22, 173-179.
-
[14]
Ming-hua LI, Shao-you LI, Hou-jun XIA, Lu WANG, Yuan-yuan WANG, Gao-hong ZHANG, Yong-tang ZHENG, 2007: Establishment of AIDS Animal Model with SIVmac239 Infected Chinese Rhesus Monkey, Virologica Sinica, 22, 509-516.
-
[15]
陆承平, 2005: An Introduction to the Animal Viruses in 8th Report of ICTV, Virologica Sinica, 20, 682-688.
-
[16]
Yi-ming SHAO, 2007: AIDS Research and Its Role in China's AIDS Prevention and Control Policies, Virologica Sinica, 22, 421-423.
-
[17]
蒋岩, 1997: Research advances of animal models of murine AIDS for evaluation of anti - AIDS treatment, Virologica Sinica, 12, 1-.
-
[18]
戴凯凡, 刘颖, 周小云, 王芙, 段丹丽, 吴岚, 赵斌, 邵一鸣, 2003: Construction of Recombinant Vaccinia Virus for Expressing gagpol Gene of Chinese Epidemic HIV-I Strain(CN54,clade B’/C), Virologica Sinica, 18, 441-445.
-
[19]
Zhi-feng Qin, Jie Sun, Ti-kang Lu, Shao-ling Zeng, Qun-yi Hua, Qing-yan Ling, Shu-kun Chen, Jian-qiang Lv, Cai-hong Zhang, Bing Cheng, Zhou-xi Ruan, Ying-zuo Bi, Joseph J Giambrone, Hong-zhuan Wu, 2012: Subtyping Animal Influenza Virus with General Multiplex RT-PCR and Liquichip High Throughput (GMPLex), Virologica Sinica, 27, 120-131. doi: 10.1007/s12250-012-3232-2
-
[20]
方勤, 刘娟, 白志强, 康涛, 何之恒, 胡志红, , 2006: Seroprevalence of Kaposi’s sarcoma-associated Herpesvirus in the General Population from Hubei province, Virologica Sinica, 21, 97-101.